nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AMPA receptor inhibitors
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 218- 1 p. |
artikel |
2 |
Balanced angiotensin II receptor antagonist
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 218- 1 p. |
artikel |
3 |
Cerebrus — contract CNS discovery research
|
Hughes, David |
|
1996 |
1 |
5 |
p. 176-177 2 p. |
artikel |
4 |
Combinatorial chemistry
|
Terrett, Nick |
|
1996 |
1 |
5 |
p. 222- 1 p. |
artikel |
5 |
Design principles for orally bioavailable drugs
|
Navia, Manuel A. |
|
1996 |
1 |
5 |
p. 179-189 11 p. |
artikel |
6 |
Drug discovery and drug metabolism
|
Cashman, John R. |
|
1996 |
1 |
5 |
p. 209-216 8 p. |
artikel |
7 |
Emerging molecular targets
|
Wallace, Robert W. |
|
1996 |
1 |
5 |
p. 223- 1 p. |
artikel |
8 |
Enantioselective total synthesis of (+)-duocarmycin A
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 219- 1 p. |
artikel |
9 |
Genomics at the AAAS
|
|
|
1996 |
1 |
5 |
p. 177-178 2 p. |
artikel |
10 |
Glycopeptide-and carbohydratebased synthetic vaccines for the immunotherapy of cancer
|
Rao Koganty, R. |
|
1996 |
1 |
5 |
p. 190-198 9 p. |
artikel |
11 |
Neuronal calcium channel blocker
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 218- 1 p. |
artikel |
12 |
Nonpeptide somatostatin ligand
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 218- 1 p. |
artikel |
13 |
Novartis who?
|
Jack, David B. |
|
1996 |
1 |
5 |
p. 176- 1 p. |
artikel |
14 |
Novel pharmacological approaches to the treatment of asthma: status and potential of therapeutic classes
|
Duplantier, Allen J. |
|
1996 |
1 |
5 |
p. 199-208 10 p. |
artikel |
15 |
Penochalasins
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 217- 1 p. |
artikel |
16 |
Piezoelectric IgM immunosensor
|
|
|
1996 |
1 |
5 |
p. 223- 1 p. |
artikel |
17 |
Potential atypical antipsychotic agents
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 217-218 2 p. |
artikel |
18 |
Preparation of secondary amines
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 220- 1 p. |
artikel |
19 |
Questioning models
|
Marriott, Chris |
|
1996 |
1 |
5 |
p. 175- 1 p. |
artikel |
20 |
Selective cleavage of ketals and acetals
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 219- 1 p. |
artikel |
21 |
Selective estrogen receptor modulators
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 217- 1 p. |
artikel |
22 |
Solid-phase synthesis of 2′ and 3′-aminonucleoside triphosphates
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 219-220 2 p. |
artikel |
23 |
Synthesis of benzo[c]-thiophenes
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 220- 1 p. |
artikel |
24 |
Synthesis of fused 1,2,4-thiadiazoles
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 220- 1 p. |
artikel |
25 |
Synthesis of pyrrolo [2,1 c][1,4]benzodiazepie antibiotics
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 219- 1 p. |
artikel |
26 |
Therapeutic profile: Diabetic complications
|
Dell, Colin P. |
|
1996 |
1 |
5 |
p. 221-222 2 p. |
artikel |
27 |
Total synthesis of antifungal FR-900848
|
Lloyd, Andrew W. |
|
1996 |
1 |
5 |
p. 219- 1 p. |
artikel |